## **Core Concept**
The question tests knowledge on the prevention of tuberculosis (TB), specifically focusing on the chemoprophylaxis of latent TB infection (LTBI). The goal of TB prophylaxis is to prevent the progression from latent infection to active TB disease.

## **Why the Correct Answer is Right**
Isoniazid (INH) is widely recognized as the first-line drug for the prophylaxis of tuberculosis. It is effective in preventing the progression of latent TB infection to active TB disease, particularly in high-risk populations such as individuals with recent exposure to TB, those with HIV/AIDS, and children. Isoniazid works by killing the dormant bacteria that cause TB, thereby preventing the development of active disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Rifampicin is a key component of the regimen for active TB treatment but is not typically used alone for prophylaxis due to the risk of resistance development. It can be used in combination with INH for certain indications but is not the first choice for monotherapy in prophylaxis.
- **Option B:** Ethambutol is another drug used in the treatment of active TB but is not the preferred choice for prophylaxis due to its potential for optic neuritis and the availability of more effective and safer alternatives like INH.
- **Option C:** Pyrazinamide is used in combination with other drugs for the treatment of active TB. While it has a role in treating latent TB, especially in combination with INH for a shorter duration (as in the 3HP regimen), INH monotherapy remains a standard for prophylaxis.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that Isoniazid prophylaxis is recommended for individuals with a positive tuberculin skin test (TST) or interferon-gamma release assay (IGRA) result, especially in high-risk groups. The standard duration of INH prophylaxis is 6-9 months, and it is crucial to monitor for potential side effects, such as hepatotoxicity.

## **Correct Answer:** . Isoniazid